P1.10-03 Gut Microbiota and Lung Cancer: A Mendelian Randomisation Study
H. Zhou,J. Liu,Y. Zhang,W. Fang,Y. Yang,S. Hong,Y. Huang,L. Zhang
DOI: https://doi.org/10.1016/j.jtho.2019.08.1065
IF: 20.121
2019-01-01
Journal of Thoracic Oncology
Abstract:Several studies have highlighted the association between the gut microbiota and lung cancer. However, robust epidemiological evidence able to discern this causal relationship does not exist. We aimed to investigate whether gut microbiota is causally associated with lung cancer through a two-sample Mendelian randomisation (MR) approach. Genetic instrumental variables of 23 genera at genome-wide significance (P < 5×10-8) were obtained from five available genome-wide association study (GWAS) of the gut microbiota. We conducted a two-sample MR analysis to access the causality between 23 genera of gut microbiota and lung cancer, based on the publicly available GWAS summary data from the International Lung Cancer Consortium (ILCCO, 11 348 lung cancer cases and 15 861 controls) and other consortiums. We applied several different MR methods for deriving causal estimates: Wald ratio, inverse-variance weighted, weighted median, and MR-Egger. Additional sensitivity analyses were utilized to detect potential pleiotropy bias. Among 23 genera, a 1 allele increase in single nucleotide polymorphisms related to higher Oscillospira was associated with a 26.1% lower risk of lung cancer (odds ratio (OR) 0.739, 95% confidence interval (CI) 0.570 to 0.959, P = 0.023). We also identified genetic predisposition towards higher Weissella, based on 1 SNP, was associated with lower risk of lung cancer (OR 0.804, 95% CI 0.693 to 0.933, P = 0.004). No associations were found for the other 21 genera, namely Acidaminococcus, Acinetobacter, Aggregatibacter, Anaerostipes, Atopobium, Bacteroides, Bifidobacterium, Coprococcus, Desulfovibrio, Dorea, Eggerthella, Eubacterium, Faecalibacterium, Lachnospira, Lactobacillus, Leuconostoc, Megamonas, Mogibacterium, Pseudobutyrivibrio, Roseburia, and Slackia.Table 1Mendelian randomisation estimates of the associations between 23 gut microbiota and risk of lung cancer.MicrobiotaSNPIVW / (Wald ratio, SNP<3)Weighted medianMR-EggerOR (95% CI)P valueOR (95% CI)P valueOR (95% CI)P valueAcidaminococcus51.001 (0.999, 1.004)0.3551.001 (0.998, 1.004)0.4241.000 (0.996, 1.005)0.894Acinetobacter11.193 (0.984, 1.447)0.073Aggregatibacter10.960 (0.884, 1.043)0.335Anaerostipes20.989 (0.933, 1.048)0.701Atopobium10.940 (0.876, 1.008)0.083Bacteroides50.999 (0.997, 1.000)0.1340.999 (0.997, 1.000)0.1520.999 (0.997, 1.000)0.213Bifidobacterium21.008 (0.934, 1.087)0.844Coprococcus11.138 (0.732, 1.769)0.567Desulfovibrio20.992 (0.958, 1.028)0.658Dorea11.058 (0.984, 1.137)0.128Eggerthella11.001 (0.998, 1.005)0.442Eubacterium10.999 (0.922, 1.083)0.987Faecalibacterium31.004 (0.952, 1.058)0.8891.002 (0.947, 1.060)0.9490.990 (0.907, 1.080)0.852Lachnospira11.028 (0.925, 1.141)0.609Lactobacillus20.972 (0.897, 1.054)0.497Leuconostoc10.964 (0.860, 1.081)0.533Megamonas31.016 (0.990, 1.043)0.2311.016 (0.985, 1.048)0.3070.908 (0.725, 1.137)0.556Mogibacterium0.998 (0.897, 1.110)0.973Oscillospira10.739, (0.570, 0.959)0.023*Pseudobutyrivibrio10.961 (0.877, 1.053)0.397Roseburia10.980 (0.843, 1.140)0.796Slackia10.980 (0.935, 1.027)0.401Weissella10.804 (0.693, 0.933)0.004**: P value < 0.05; IVW: inverse-variance weighted; OR: odds ratio; CI: confidence interval. Open table in a new tab *: P value < 0.05; IVW: inverse-variance weighted; OR: odds ratio; CI: confidence interval. Our present mendelian randomisation study provided evidence of a causal effect of the gut microbiota on lung cancer, suggesting Oscillospira and Weissella might be the focus of future research. Further studies are needed to confirm these causality and elucidate the potential mechanisms.